New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - digoxin 0.0625mg;  ;  ;  ;  ; digoxin 0.0625mg - tablet - 0.0625 mg - active: digoxin 0.0625mg         excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone pregelatinised maize starch purified water rice starch active: digoxin 0.0625mg excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone purified water rice starch starch, oxidised - cardiac failure:- lanoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. its therapeutic benefit is greatest in those patients with ventricular dilatation. lanoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation. supraventricular arrhythmias:- lanoxin is indicated in the management of certain supraventricular arrhythmias, particularly atrial flutter and fibrillation, where a major beneficial effect is reduction of the ventricular rate.

Ireland - English - HPRA (Health Products Regulatory Authority)

breathe pharmaceuticals limited - salbutamol sulfate - nebuliser solution - 2.5/2.5 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

breathe pharmaceuticals limited - salbutamol sulfate - nebuliser solution - 5/2.5 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

napp laboratories limited - salbutamol sulfate - withdrawn form - 50 international unit

Ireland - English - HPRA (Health Products Regulatory Authority)

napp laboratories limited - salbutamol sulfate - withdrawn form - 500 international unit

Ireland - English - HPRA (Health Products Regulatory Authority)

napp laboratories limited - salbutamol sulfate - 1000 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

napp laboratories limited - salbutamol sulfate - syrup - 0.4 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

napp laboratories limited - salbutamol sulfate -

Ireland - English - HPRA (Health Products Regulatory Authority)

napp laboratories limited - salbutamol sulfate - 5 milligram

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - salbutamol 2 mg/ml equivalent to 100 µg/dose - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol 2 mg/ml equivalent to 100 µg/dose excipient: dichlorodifluoromethane lecithin sorbitan trioleate trichlorofluoromethane